Role of Proteasomes in Cellular Regulation
Introduction
Degradation of cellular proteins is a tightly regulated process, carried out by the cascade of the proteasome‐ubiquitin pathway. The 26S proteasome, an intensively studied protease, represents the sophisticated complex of subunits and is critical for life. This complex is implicated in the temporally controlled ATP‐dependent degradation of key regulatory proteins controlling main cellular processes (cell cycle, apoptosis, differentiation, development, immune response, malignant transformation), as well as in regulation of different stages of gene expression (Collins and Tansey, 2006, Ferdous et al., 2007, Glickman and Ciechanover, 2002, Kloetzel, 2004, Maupin‐Furlow et al., 2006, Pajonk and McBride, 2001, Reed, 2006, Sikder et al., 2006, Wojcik et al., 2000).
The participation of the proteasome‐ubiquitin pathway in the control of degradation of regulatory proteins involves not only the regulation of the complicated enzyme system of conjugation of the ubiquitin molecules to the substrates but also the highly complex control of the composition and the activities of the proteasome particle itself. These particles are heterogeneous due to subtypes synthesized from duplicated genes and/or alternative splicing, to posttranslational modifications and to association of 20S core with alternative regulatory complexes (Glickman and Raveh, 2005, Maupin‐Furlow et al., 2006). Here we will describe recent studies revealing the current knowledge about proteasomes involvement in the fundamental biological processes such as control of cell cycle, apoptosis, differentiation, modulation of immune responses, about their isoform complexity including subunits' posttranslational modifications, structural and functional responsiveness to cell requirements and participation of these particles in the main stages of gene expression.
Section snippets
The core particle, 19S regulatory particle, alternative regulatory particles
The 26S proteasome, further often named “the proteasome, ” is an ATP‐dependent multicatalytic enzyme complex found in the nucleus and cytoplasm not only of all eukaryotic cells, but also of Archebacteria and in some Eubacteria. Proteasomes are responsible for the degradation of most cellular proteins (Coux et al., 1994). The 26S proteasomes constitutes the central proteolytic machinery of the ubiquitin/proteasome system, and is composed of a core catalytic complex, called 20S proteasome, capped
Cell cycle control
The cell cycle in eukaryotes is regulated by consecutive activation of cyclin‐dependent kinases (CDKs) by various cyclins. Cyclins are synthesized during strongly defined moments of a cell cycle and, being the extremely unstable, exist and work only at the certain phases of the cell cycle and during the certain period of time. For example, cyclins D and E are active during phase G1; cyclins E and A, during phase S. Consecutive appearance and disappearance of the pairs cyclin‐CDK at various
Heterogeneity of proteasomes in the cell
The more in a complicated manner the organization of both the separate cells, and the entire organisms is, the more fancily becomes the main cellular machinery, aimed to non‐lysosomal protein cleavage. The structure and sub‐unit content of ancestral proteasome complex found in Prokaryota, both Archea (Maupin-Furlow and Ferry, 1995) and Eubacteria (Hu et al., 2006, Lupas et al., 1994, Tamura et al., 1995), is respectively simple: subunits are divided into only two types, α and β, forming four
Reprogramming of Proteasomes at Immune Response, Differentiation and Apoptosis
It was mentioned above that the proteasomes play important roles in most cellular processes. To perform their functions, proteasomes must be under a tight regulatory control and change their subunit composition and enzymatic activities to adapt them to the requirements of the each of the cellular processes during the cell life. Phosphorylation at serine, threonine, or tyrosine residues of regulatory proteins is the key event in signal transduction and cell cycle progression (Coux et al., 1996).
Action at multiple stages of transcription process
A growing body of evidence reveals that proteasomes are involved in the control of different levels of gene expression: transcription process, messenger RNA stability and translation.
The physical and functional association of subunits of the 20S core and 19S regulatory proteasome subparticles with approximately 6400 yeast genes has been studied (Sikder et al., 2006). The results revealed the cross‐linking of the intact 26S proteasomes to most genes, while several hundred genes interacted with
Concluding Remarks
Recent evidence show that proteasomes are involved in the control of the main cellular processes as well as in the main stages of gene expression and that these complexes themselves are subjected to tightly organized regulation. However, the cellular pathways of this regulation (enzymes responsible for modifications of subunits, control pathways of their activity, mechanisms of the regulation of subunit expression, of cellular localization and others) remain mainly uninvestigated.
Furthermore,
Acknowledgments
This work was supported by Russian Foundation for Basic Research (project No. 08‐04‐00834) and St. Petersburg's Scientific Center of Russian Academy of Sciences.
References (334)
Potential for proteasome inhibition in the treatment of cancer
Drug Discov. Today
(2003)The proteasome: Structure, function, and role in the cell
Cancer Treat. Rev.
(2003)- et al.
Potent and selective inhibitors of the proteasome: Dipeptidyl boronic acids
Bioorg. Med. Chem. Lett.
(1998) - et al.
Caspase‐dependent inactivation of proteasome function during programmed cell death in Drosophila and man
J. Biol. Chem.
(2004) - et al.
Developmental regulation of proteolytic activities and subunit pattern of 20S proteasome in chick embryonic muscle
J. Biol. Chem.
(1991) - et al.
Human immunodeficiency virus‐1 Tat protein interacts with distinct proteasomal alpha and beta subunits
FEBS Lett.
(2003) - et al.
Genomic association of the proteasome demonstrates overlapping gene regulatory activity with transcription factor substrates
Mol. Cell
(2006) - et al.
Biochemical identification of proteasome‐associated endonuclease activity in sunflower
Biochem. Biophys. Acta
(2003) - et al.
Chlorogenic acid inhibits Bcr‐Abl tyrosine kinase and triggers p38 mitogen‐activated protein kinase‐dependent apoptosis in chronic myelogenous leukemic cells
Blood
(2004) - et al.
20S proteasome differentially alters translation of different mRNAs via the cleavage of eIF4F and eIF3
Mol. Cell
(2004)
The proteasome: Paradigm of a self‐compartmentalizing protease
Cell
Subcellular distribution and profiles of prosomes (proteasomes‐MCP) during differentiation of human lymphoblastic cell line
Leuk. Res.
Role of SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 during S‐phase
J. Biol. Chem.
Ubiquitin‐mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction
J. Biol. Chem.
Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion
J. Biol. Chem.
Induction of G1 arrest and apoptosis in human jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/WAF1, and Bax proteins
J. Biol. Chem.
The ubiquitin system: Pathogenesis of human diseases and drug targeting
Biochim. Biophys. Acta
Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment
Blood
Mapping and structural dissection of human 20S proteasome using proteomic approaches
Mol. Cell Proteomics
The proteasome: A utility tool for transcription?
Curr. Opin. Genet. Dev.
Different proteasome subtypes in a single tissue exhibit different enzymatic properties
J. Mol. Biol.
Subtypes of 20S proteasomes from skeletal muscle
Biochimie
Identification, purification, and characterization of a PA700‐dependent activator of the proteasome
J. Biol. Chem.
Glutathiolation of the proteasome is enhanced by proteolytic inhibitors
Arch. Biochem. Biophys.
20S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S‐glutathionylated
J. Biol. Chem.
Proteasome inhibition alters the transcription of multiple yeast genes
Biochim. Biophys. Acta
Purification of an 11S regulator of the multicatalytic proteinase
J. Biol. Chem.
Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3
Mol. Cell
Mdm2 is a RING finger‐dependent ubiquitin protein ligase for itself and p53
J. Biol. Chem.
Inactivation of the proteasome by 4‐hydroxy‐2‐nonenal is site specific and dependant on 20S proteasome subtypes
Arch. Biochem. Biophys.
A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p
Cell
Lactacystin, proteasome function, and cell fate
J. Biol. Chem.
The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II
Mol. Cell
In vivo and in vitro phosphorylation of Candida albicans 20S proteasome
Arch. Biochem. Biophys.
SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase
J. Biol. Chem.
Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma)
Arch. Biochem. Biophys.
The proteasome: Destroy to live
Mol. Biol. (Mosk).
Changes in proteasome activity and subunit composition during postnatal development of rat
Ontogenes
Proteasome inhibitors as new anticancer drugs
Curr. Opin. Oncol.
Proteasome inhibitors: A novel class of potent and effective antitumor agents
Cancer Res.
Proteasome inhibition: A new strategy in cancer treatment
Invest. New Drugs
Interferon‐gamma induces different subunit organizations and functional diversity of proteasomes
J. Biochem. (Tokyo)
Novel dipeptidyl proteasome inhibitors overcome Bcl‐2 protective function and selectively accumulate the cyclin‐dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts
Cell Death. Differ.
Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active‐site formation
Proc. Natl. Acad. Sci. USA
Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N‐terminal acetylation and promote particle assembly
EMBO J.
Transcriptional regulation by the proteasome as a mechanism for cellular protein homeostasis
Cell Cycle
Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome‐dependent proteolysis of the cyclin‐dependent inhibitor p27
Cell Growth Differ.
Large‐scale characterization of HeLa cell nuclear phosphoproteins
Proc. Natl. Acad. Sci. USA
Nuclear multicatalytic proteinase α subunit RRC3: Differential size, tyrosine phosphorylation, and susceptibility to antisense oligonucleotide treatment
Biochemistry
Proteasome activities decrease during dexamethasone‐induced apoptosis of thymocytes
Biochem. J.
Cited by (148)
Coordinated regulation of the ribosome and proteasome by PRMT1 in the maintenance of neural stemness in cancer cells and neural stem cells
2021, Journal of Biological ChemistryBiochemical pathways of copper complexes: progress over the past 5 years
2021, Drug Discovery TodayOptions for Chemotherapy and Scoring Response and Relapse
2020, Hematology/Oncology Clinics of North America